Answers are grounded in this paper and cite their sources.
DNA mismatch repair and microsatellite instability (MSI) status are important biomarkers that guide clinical management and therapeutic decision-making in colorectal cancer (CRC). The prevalence of mismatch repair deficiency (dMMR) and high microsatellite instability (MSI-H) in CRC has been associated with clinicopathological features including anatomical site of origin in the colorectum and patient age at diagnosis. However, estimates of the prevalence of dMMR/MSI-H in CRC can vary widely due to differing selection biases between cohorts and potential confounders such as cancer stage, patient sex, and genetic ancestry. In this review, we conducted a comprehensive search of PubMed, EMBASE, and Web of Science databases from 1 January 2010 to 1 November 2024, to summarize recent evidence on the prevalence of dMMR/MSI-H in CRC. We critically evaluate factors influencing prevalence estimates and discuss how these insights inform our understanding of the biological heterogeneity of dMMR/MSI-H CRC.
No takes yet. Share an insight, caveat, or question.
Ward et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: